Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Latin America Flow Cytometry Market Worth $566.5 Million By 2022: Grand View Research, Inc.


News provided by

Grand View Research, Inc.

18 Nov, 2015, 13:15 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Grand View Research Logo (PRNewsFoto/Grand View Research_ Inc_)

SAN FRANCISCO, November 18, 2015 /PRNewswire/ --

Latin America flow cytometry market is expected to reach USD 566.5 million by 2022, according to a new report by Grand View Research Inc. Increasing target disease population base, high unmet needs and demand for rapid, accurate diagnostic tools are key factors driving the Latin America flow cytometry market over the forecast period.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

Increasing demand for faster and accurate leukemia prognostic tools coupled with increasing prevalence rate is expected to provide this market with lucrative growth platform in near future. In addition, research pertaining to drug development, stem cell therapy and in vitro toxicity testing are expected to fuel the market growth over the forecast period.

Browse full research report with TOC on "Latin America Flow Cytometry Market Analysis By Technology (Cell Based, Bead Based), By Product and Services (Instruments, Reagents & Consumables, Accessories, Software), By Application (Research, Clinical, Pharmaceutical, Apoptosis, Cell Sorting, Cell Cycle Analysis, Immunology, Cell Viability, Industrial, Cancer, Hematology, Immunodeficiency Diseases), By End-use (Commercial Organization, Hospitals, Academic Institutes, Clinical Testing Labs) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/latin-america-flow-cytometry-market                                                                                                                                            

According to the data published by WHO, it has been estimated that in 2012, cancer incidences (cases per year) were nearly 603,400 patients. Furthermore, risk of getting cancer before age 75 accounted for 18% in Latin America. Moreover, experts suggest that on account of rising prevalence of infectious diseases, the aforementioned prevalence rate is expected to rise over the next decade. All the aforementioned facts are expected to push demand for rapid diagnostic tools which in turn is expected to provide lucrative growth to this industry in near future.

Further key findings from the report suggest: 

  • Bead based technology is expected to grow at a lucrative CAGR of about 12.0% over the forecast period. The bead based flow cytometry is used to measure a variety of intracellular proteins and solubles including growth factors, phosphorylated cell signaling proteins, chemokines and cytokines. Rising demand for infectious disease diagnostic assays is expected to spearhead growth during the forecast period.
  • Flow cytometry found the largest application in research in 2014. The segment is likely to dominate the market throughout the forecast period accounting for over 54.0% of the revenue by 2022. This dominance is attributed to rising research activities pertinent to leukemia and increasing usage of ISH probes such as miRCURY LNA microRNA and Prime Flow RNA for RNA research and quantification.
  • The clinical application segment of this market is majorly driven by the growing demand of immunodeficiency related R&D. The segment accounted for over 29.0% of the market in 2014, owing to the rising prevalence of immunodeficiency diseases in children and infants.
  • The market for instruments held an appreciable revenue share of over 43.0% in 2014. The introduction of novel technology such as multicolor flow cytometer and simultaneous multiparameter detection features are some factors contributing towards robust market growth. In addition, growing R&D activities, and widening application of flow cytometry applications in drug discovery & development, genomic and molecular analysis are also expected to drive segment growth during the forecast period.
  • The clinical testing labs segment is expected to grow at the fastest CAGR of 10.7% over the forecast period. Rising adoption of flow cytometry owing to the associated benefits such as fast results, and providing quantitative information for clinical trials of drug compound in phase I clinical trials are expected to fuel demand during the forecast period.
  • Key players of this market include Life Technologies Corporation, Beckman Coulter Inc, EMD Millipore Corp, Stratedigm, Sysmex Corporation, Miltenyi Biotec, Becton Dickinson and Co and Luminex Corporation is major players in the Latin America flow cytometry market.
  • Market participants are striving to gain competitive advantage by introducing new products and services mostly via collaborative agreements. For example, in September 2015, BD Life Sciences entered into a collaborative agreement with Seegene for developing multiplex PCR reagents used in BD max system.

Grand View Research has segmented the Latin America Flow Cytometry market on the basis of technology, product and service, applications, and end use:

  • Latin America Flow Cytometry Technology Outlook (Revenue, USD Million, 2012 - 2022) 
    • Cell based
    • Bead based
  • Latin America Flow Cytometry Product and Services Outlook (Revenue, USD Million, 2012 - 2022) 
    • Instruments
    • Reagents and consumables
    • Software
    • Accessories
    • Services
  • Latin America Flow Cytometry Application Outlook (Revenue, USD Million, 2012 - 2022) 
    • Research
      • Pharmaceutical
        • Drug Discovery
        • Stem cell research
        • In vitro toxicity
      • Apoptosis
      • Cell sorting
      • Cell cycle analysis
      • Immunology
      • Cell viability
    •  Industrial
    • Clinical
      • Cancer
      • Organ transplantation
      • Immunodeficiency diseases
      • Hematology
  • Latin America Flow Cytometry End Use Outlook (Revenue, USD Million, 2012 - 2022) 
    • Commercial organizations
    • Hospitals
    • Academic institutes
    • Clinical testing labs
  • Latin America Flow Cytometry Country Outlook (Revenue, USD Million, 2012 - 2022) 
    • Mexico
    • Guatemala
    • Costa Rica
    • Panama
    • Republica Dominicana
    • Cuba
    • Brazil
    • Colombia
    • Venezuela
    • Ecuador
    • Peru
    • Argentina
    • Chile
    • Uruguay

Browse related reports by Grand View Research: 

  • Radiotherapy Market - http://www.grandviewresearch.com/industry-analysis/radiotherapy-market  
  • Temperature Management Market - http://www.grandviewresearch.com/industry-analysis/temperature-management-market  
  • Lung Cancer Surgery Market - http://www.grandviewresearch.com/industry-analysis/lung-cancer-surgery-market  
  • Cardiovascular Information System Market - http://www.grandviewresearch.com/industry-analysis/cardiovascular-information-system-market                                              

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - legalworkshop.org, grandviewresearchinc.blogspot.com  


Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com  

Modal title

Also from this source

Vineet Agarwal Joins Grand View Research as Investor and Board Member

Vineet Agarwal Joins Grand View Research as Investor and Board Member

We are pleased to announce that Vineet Agarwal, a seasoned business leader and investor with over 20 years of experience in strategy, research &...

Grand View Research's Latest Market Research Findings Predict Major Shifts in Flooring Market by 2030

Grand View Research's Latest Market Research Findings Predict Major Shifts in Flooring Market by 2030

The global flooring market size is estimated to reach USD 534.6 billion by 2030, registering a CAGR of 6.8% from 2025 to 2030, according to a new...

More Releases From This Source

Explore

Chemical

Chemical

Chemical

Chemical

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.